Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta‐analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta‐analysis
Authors
Keywords
-
Journal
ACTA NEUROLOGICA SCANDINAVICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-18
DOI
10.1111/ane.13387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fenfluramine acts as a positive modulator of sigma-1 receptors
- (2020) Parthena Martin et al. EPILEPSY & BEHAVIOR
- Recent Advances in the Drug Treatment of Dravet Syndrome
- (2019) Elaine C. Wirrell et al. CNS DRUGS
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
- (2019) Lieven Lagae et al. LANCET
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
- (2019) Rima Nabbout et al. JAMA Neurology
- Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors
- (2018) María Rodríguez-Muñoz et al. Oncotarget
- Individualized treatment approaches: Fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome
- (2018) Tilman Polster EPILEPSY & BEHAVIOR
- Current Treatment Strategies and Future Treatment Options for Dravet Syndrome
- (2018) Julie Ziobro et al. Current Treatment Options in Neurology
- A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
- (2018) Brooks Boyd et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
- (2017) Elaine C. Wirrell et al. PEDIATRIC NEUROLOGY
- Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
- (2017) Jo Sourbron et al. Frontiers in Pharmacology
- Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine
- (2016) Berten Ceulemans et al. EPILEPSIA
- Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study
- (2016) Paola De Liso et al. EPILEPSY RESEARCH
- Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
- (2016) A. Schoonjans et al. EUROPEAN JOURNAL OF NEUROLOGY
- The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome
- (2015) Luis Miguel Aras et al. EPILEPSY & BEHAVIOR
- Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
- (2015) Byung Chan Lim et al. EPILEPSY RESEARCH
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief
- (2011) Joan V. Skluzacek et al. EPILEPSIA
- Genotype-phenotype associations in SCN1A-related epilepsies
- (2011) S. M. Zuberi et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now